Eylea prefilled syringe approval leads weekly ophthalmology headlines

Here are some of the recent top stories on Healio.com/OSN:
 
FDA approves Eylea prefilled syringe
The 2-mg, single-dose, sterilized prefilled Eylea (aflibercept) syringe, which requires fewer preparation steps compared with vials, is expected to be available by the end of the year. Read more.
 
BioTime rebrands as Lineage Cell Therapeutics
BioTime has changed its name to Lineage Cell Therapeutics to better reflect its commitment to becoming a leading cell therapy company. Read more.
 
Alembic’s generic dorzolamide hydrochloride solution approved
Indicated for the treatment of

Full Story →